Biodesix, Inc. (BDSX) investor relations documents from the company's IR site: 1 presentation, 35 press releases; latest deck 2026-08-04. Read in-app with summaries. First-party data.
Corporate Presentation: Biodesix is a lung-focused diagnostics company that reported $26.9M in Q2 2026 revenue, maintaining its full-year guidance of $108M to $114M.
BDSX overview · BDSX earnings · BDSX financials · BDSX KPIs · BDSX documents · BDSX ownership · BDSX peers
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.